InterShunt
About:
InterShunt designs and develops a catheter based minimally-invasive procedure to provide relief for millions suffering from heart failure.
Website: https://intershunt.com/
Top Investors: gbeta, MedTech Innovator, Solas BioVentures, Arsenal Capital Management, Accelerate Venture Partners
Description:
InterShunt designs and develops a catheter-based minimally-invasive procedure to provide relief for millions suffering from heart failure. It believes that left atrial decompression holds the key to reducing symptoms for those who suffer. It also believes that they can do this using a simple catheter procedure. Most importantly, they believe they can do this without the use of an implant. It was founded in 2015 and is headquartered in St Louis, Missouri.
$8.02M
$1M to $10M
St Louis, Missouri, United States
2015-01-01
Gil Vardi
1-10
2023-06-06
Private
© 2025 bioDAO.ai